PRP Injections and Their Effectiveness on Osteoarthritis

PRP injections for osteoarthritis offer a promising treatment option to manage pain and enhance mobility in affected joints.

Abstract

In this educational post, I will guide you through the complex landscape of injection therapies for knee osteoarthritis (OA) and other musculoskeletal conditions, a set of challenges I see frequently in my practice. We will explore the latest evidence-based findings on common treatments, including corticosteroids, ketorolac, hyaluronic acid (HA), and platelet-rich plasma (PRP). My goal is to demystify these options, presenting a clear, easy-to-understand journey from rapid, short-term relief to long-term, structurally focused solutions. I will break down the physiological mechanisms of each treatment, discuss their respective benefits and risks, and explain the clinical reasoning for choosing one over another, with a particular focus on the critical role of PRP dosage. Furthermore, I will integrate modern medical approaches with the principles of integrative chiropractic care, showing how a holistic strategy that includes spinal health, biomechanics, and lifestyle modifications can significantly improve treatment outcomes and support the body’s innate healing capacity.

The Common Dilemma: A Case of Acute Knee Pain

Let me start with a scenario that is all too familiar in my clinical practice. A 60-year-old woman comes to my office with an acute flare-up of right knee pain. She leads an active life but has a history of mild osteoarthritis. This recent flare began after a period of increased walking, and now she’s experiencing pain with stairs, mild swelling, and difficulty getting around. To add to the pressure, her son’s wedding is just a week away, and she is desperate for a solution that will allow her to participate fully and without pain.

This case presents a classic clinical crossroads. What is the best course of action? Many practitioners would immediately default to an intra-articular corticosteroid injection. But is that the best choice, not just for next week, but for the long-term health of her knee? Let’s delve into the evidence together and explore the options so that you can make an informed decision about your own health journey.

Corticosteroids: Rapid Relief at a Potential Cost

The primary reason corticosteroids are so widely used is their powerful and rapid anti-inflammatory effect.

• Mechanism of Action: Steroids work by suppressing synovial inflammation, which is a key driver of pain and swelling in an OA flare-up. They inhibit the infiltration of immune cells (leukocytes) into the joint and downregulate genes involved in the inflammatory cascade.
• Clinical Outcome: This leads to a rapid reduction in pain and effusion, typically within 3 to 7 days. For our patient with the upcoming wedding, this seems like the perfect solution to get her pain under control quickly.

The Downside of Steroids: A Closer Look at the Evidence

While the short-term benefits are clear, we must consider the significant risks and long-term consequences associated with corticosteroids. My approach to patient care is always rooted in the principle of “first, do no harm,” which means weighing the potential for immediate relief against the risk of future damage.

• Systemic Effects: A single injection can elevate blood glucose levels for up to a week, making it a risky choice for individuals with uncontrolled diabetes. There are also concerns about adrenal suppression and negative impacts on bone mineral density, particularly for postmenopausal women and men over 50.
• Chondrotoxicity (Cartilage Damage): This is my most significant concern. Robust preclinical data show that steroids have dose-dependent deleterious effects on cartilage cells. In simple terms, the higher the dose, the more toxic it is to the very tissue we are trying to protect.
• Clinical Research Findings: A landmark 2017 study published in JAMA confirmed these fears. In this two-year randomized controlled trial, patients receiving regular triamcinolone injections (a common steroid) experienced significantly greater cartilage volume loss compared to those receiving a saline placebo, with no significant difference in long-term pain relief (McAlindon et al., 2017).
• Increased Risk of Surgery: Another large retrospective study found that patients who received even one to three steroid injections (for non-OA conditions) had a twofold greater risk of needing a total knee arthroplasty (TKA) within five years. This risk increased with each subsequent injection (Wijn et al., 2020).

From an integrative perspective, repeatedly injecting a substance known to degrade cartilage runs counter to our goal of promoting joint health and longevity. It’s a short-term fix that can accelerate the underlying disease process. This has led many of us in the field to seek safer, more sustainable alternatives.

Ketorolac: A Safer Alternative for Rapid Inflammation Control

If we need to manage an acute inflammatory flare like our quick patients, but want to avoid the chondrotoxic effects of steroids, what can we use? An excellent alternative is an intra-articular injection of ketorolac, a non-steroidal anti-inflammatory drug (NSAID).

• Mechanism of Action: Ketorolac works by inhibiting the COX-1 and COX-2 enzymes, thereby blocking the production of prostaglandins—key molecules that drive inflammation and pain sensitization. When delivered directly into the joint, it achieves high concentrations where it’s needed most, with minimal systemic exposure compared to oral NSAIDs.
• The Key Difference: While it provides powerful anti-inflammatory and analgesic effects similar to steroids, ketorolac lacks the same gene-altering, immunosuppressive, or chondrotoxic properties.
• Clinical Evidence: A 2022 systematic review and meta-analysis demonstrated that intra-articular ketorolac provides pain and functional improvements comparable to corticosteroids from one week to three months post-injection, with minimal adverse events (Catapano et al., 2022). Our own clinical research on hip pathologies has shown similar promising results, with ketorolac even outperforming steroids for OA pain.
• Onset of Action: Patients often experience relief within a few days, making it a viable option for acute situations.

Ketorolac represents a “steroid-sparing” strategy. It allows us to address the immediate goal of rapid pain relief without compromising the structural integrity of the joint cartilage. However, it is still a short-term solution. It should be used with caution in individuals with contraindications to NSAIDs, such as a history of ulcers, kidney disease, or cardiac issues.

Hyaluronic Acid (HA): Lubricating the Joint for Longer-Term Function

What if the patient’s primary concern isn’t an acute flare but rather chronic, grinding pain? Or what if they want to focus on improving the long-term health of their joint? This is where we shift our thinking from simply putting out an inflammatory fire to improving the joint’s internal environment. This brings us to hyaluronic acid (HA), also known as viscosupplementation.

• Physiological Rationale: Think of HA as the joint’s natural lubricant and shock absorber. In an osteoarthritic joint, the native HA is depleted and broken down, leading to reduced viscosity of the synovial fluid. This results in increased friction, inflammation, and pain. Supplementing with an HA injection aims to restore these crucial viscoelastic properties.
• Beyond Lubrication: The benefits of HA extend beyond mechanical lubrication. It also has biological effects:

• It binds to CD44 receptors on synovial cells, thereby modulating inflammation and reducing the production of cartilage-degrading enzymes (MMPs).
• It may stimulate the joint to produce its own endogenous HA.
• It can have a direct pain-reducing (antinociceptive) effect by decreasing the sensitivity of nerve endings in the joint.

• Clinical Efficacy: Evidence indicates that HA injections can lead to a meaningful reduction in knee OA pain, with effects that typically peak around 2 months and can last for 6 months or longer (Richette et al., 2021). It tends to be more effective in patients under 65 with less severe radiographic OA.
• Molecular Weight Matters: Research suggests that high-molecular-weight HA formulations are more effective. They have stronger anti-inflammatory and chondroprotective properties and are more effective at stimulating the body’s own HA production than low-molecular-weight versions.

While HA is a step toward a more restorative approach, it is not considered a true disease-modifying agent. Its main role is to improve symptoms and function, potentially delaying the need for more invasive procedures.

Platelet-Rich Plasma (PRP): Harnessing the Body’s Healing Power

This brings us to the frontier of regenerative medicine and to what I consider the most promising injectable, not only for treating symptoms but also for potentially modifying the disease process itself: Platelet-Rich Plasma (PRP). PRP is a concentrate of your own blood platelets, which are cellular powerhouses of growth factors and signaling molecules that orchestrate tissue repair.

Navigating the Confusing Landscape of PRP Research

In my practice, I often encounter patients who are confused by conflicting information about PRP. Some have heard it’s a miracle cure for joint pain, while others have read studies claiming it’s ineffective. This confusion is understandable, as the scientific literature itself has presented a mixed picture. For instance, some high-profile studies reported that PRP was no more effective than a placebo. So, what accounts for this discrepancy? From my clinical perspective and a deep dive into the research, a critical variable has emerged: dose.

The Dose Makes the Difference: Unlocking PRP’s Potential

The studies that reported negative outcomes often used a relatively low platelet concentration, delivering a total dose of about 1.6-2.2 billion platelets. As we’ve come to understand, this is likely insufficient to trigger the robust biological response needed for cartilage protection and repair. For meaningful chondroprotective and pro-angiogenic (new blood vessel formation) effects, the target concentration should be significantly higher.

This concept of a dose-dependent response is a cornerstone of functional medicine—finding the right amount of an intervention to create a therapeutic effect. My colleagues and I conducted a systematic review and found a striking difference: studies reporting positive outcomes used an average total dose of approximately 5.5 billion platelets.

High-Dose PRP: A New Gold Standard for Knee Osteoarthritis?

We expanded our investigation with a comprehensive meta-regression analysis of 42 studies focused on knee OA. We stratified the data into three dosage groups to determine which was most effective:

• Low Dose: Less than 5 billion total platelets
• Medium Dose: 5 to 10 billion total platelets
• High Dose: Greater than 10 billion total platelets

The results were clear and compelling. The high-dose group showed a markedly superior clinical effect compared with the low- and medium-dose groups. To achieve this high dose, you need a PRP concentration of approximately 1.5-2 million platelets per microliter.

PRP: A Symphony of Healing

When the proper dose is injected into the knee, PRP initiates a complex biological cascade:

• Inflammation Modulation: It shifts the joint environment from a chronic, pro-inflammatory state (M1 macrophage-dominant) to an anti-inflammatory and regenerative one (M2 macrophage-dominant) primarily via the NF-κB pathway.
• Tissue Regeneration: It releases a host of growth factors (VEGF, PDGF, TGF-beta) that promote the formation of new blood vessels (angiogenesis), stimulate the proliferation of local repair cells, and encourage the differentiation of stem cells.
• Chondroprotection: Preclinical studies consistently show that PRP can decrease cartilage degeneration, increase cartilage thickness, and reduce other signs of OA progression, such as osteophyte formation.

Superior Clinical Evidence and Delaying Surgery

The body of evidence for PRP in knee OA is now vast and high-quality. A comprehensive 2023 meta-analysis, which included 16 trials and nearly 1900 patients, found that PRP demonstrated a significant advantage over hyaluronic acid, leading to greater symptom improvement and a lower rate of reintervention (Belk et al., 2023).

The ultimate goal for many patients is to avoid or delay a total knee replacement. A large 2021 study found that 85% of patients treated with PRP did not undergo a TKR within a five-year follow-up period, with a median delay of 5.3 years for those who eventually needed surgery (Sánchez et al., 2021). This is a profound and life-altering outcome for many individuals. PRP represents a paradigm shift. We are moving away from simply masking symptoms and toward actively stimulating the body’s own innate healing capabilities.

The Role of Integrative Chiropractic Care

No injection, no matter how advanced, is a “magic bullet.” True and lasting success comes from integrating these cutting-edge medical treatments into a comprehensive, holistic framework. This is where integrative chiropractic care plays an indispensable role.

As a practitioner with dual credentials in both chiropractic and advanced practice nursing, I see the body as an interconnected system. The health of a knee joint is not isolated; it is profoundly influenced by the alignment and function of the entire kinetic chain—from the feet up to the spine.

A Deeper Dive into Clinical Application

Let’s discuss how this integrative philosophy applies to some of the most challenging conditions I see in my practice.

Understanding and Treating Complex Meniscal Tears

One of the toughest presentations is a patient with a complex meniscal tear, such as a radial tear or a meniscal root tear. My approach is multifaceted:

1. Foundation First: I always begin with conservative measures. This includes weight-loss counseling and targeted physical therapy. From a chiropractic perspective, this is also where we assess and correct biomechanical imbalances in the kinetic chain. An unstable pelvis, a rotated hip, or poor foot mechanics can place undue stress on the knee, hindering any healing process. Through specific chiropractic adjustments, we can restore proper alignment to the spine and pelvis, ensuring that weight and force are distributed evenly through the lower extremities.
2. Biologic Intervention: If conservative care fails, we consider biologics like PRP. For certain tear patterns, such as a horizontal cleavage tear, an intrameniscal (directly into the meniscus) PRP injection can lead to healing in about 50% of cases and significant clinical improvement in 70-80% of patients (Blazina et al., 1970). For other tear types, an intra-articular (into the joint space) injection is more appropriate. Studies show that even intra-articular PRP can reduce the severity of a meniscal tear on MRI by at least one grade (Sanchez et al., 2012).
3. Advanced Scaffolding and Offloading: For severe gaps, like those in radial tears, I often employ a more advanced strategy. I use PRP in combination with micronized adipose tissue (MFat). The fat tissue acts as a biological scaffold, providing a structural matrix within the tear for platelets and stem cells to adhere to and initiate repair. Critically, this is paired with aggressive offloading of the joint for up to six weeks using a specialized brace. This mechanical unloading is vital; it protects the delicate healing tissue from shear and compressive forces.

Adjunctive Use of Other Injectables

A common question is whether other injectables can be used alongside biologics.

• Ketorolac and PRP: The consensus is to avoid mixing Ketorolac and PRP. Ketorolac is a potent NSAID. The entire mechanism of PRP relies on initiating a controlled inflammatory-healing cascade. NSAIDs directly interfere with platelet function and this inflammatory process, potentially blunting the therapeutic effect.
• Ketorolac and Hyaluronic Acid (HA): In contrast, combining Ketorolac with HA can be a very effective strategy. For a patient with an acute inflammatory flare, adding ketorolac (typically 30 mg) to the HA injection provides rapid pain relief while the HA begins its longer-term lubricating action. Good data support this combination (Joshi & Saltzman, 2021). However, it is crucial to screen for contraindications, particularly chronic kidney disease.

A Holistic Framework for Healing

Beyond specific interventions for the knee, an integrative approach addresses the whole person:

• Soft Tissue and Myofascial Release: Chronic knee OA is always accompanied by compensatory muscle imbalances and fascial restrictions. We utilize advanced soft-tissue techniques to release tension in the quadriceps, hamstrings, and calf muscles, thereby improving flexibility and reducing abnormal pulling forces on the knee joint.
• Functional Rehabilitation: A personalized exercise program is non-negotiable. This is about re-educating movement patterns, improving proprioception (the joint’s sense of position), and building stability around the joint to protect the healing cartilage.
• Anti-Inflammatory Lifestyle: The success of PRP and other biologics is enhanced by creating an anti-inflammatory internal environment. As a Certified Functional Medicine Practitioner, I guide my patients in nutritional strategies, targeted supplementation (such as curcumin and omega-3s), stress management, and sleep optimization to reduce systemic inflammation and support the body’s healing processes.

By combining precise, evidence-based injection therapies with a foundation of chiropractic care, functional rehabilitation, and lifestyle medicine, we create a strong combination. We not only address the pain and inflammation within the joint but also correct the underlying biomechanical and systemic factors that contributed to the problem. This is the essence of a truly integrative and patient-centered approach to managing knee osteoarthritis.

References

• Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. R., Dragoo, J. L., & McCarty, E. C. (2023). Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: A systematic review and meta-analysis of overlapping and nonoverlapping randomized controlled trials. The American Journal of Sports Medicine, 51(11), 3098–3109.
• Blazina, M. E., Kerlan, R. K., Jobe, F. W., Carter, V. S., & Carlson, G. J. (1970). Jumper’s knee. The Orthopedic Clinics of North America, 4(3), 665-678.
• Catapano, M., de Sa, D., & Horner, N. S. (2022). The role of intra-articular ketorolac in the treatment of musculoskeletal disease: A systematic review. The American Journal of Sports Medicine, 50(4), 1152–1160.
• Joshi, N. P., & Saltzman, C. L. (2021). Intra-articular injections for the treatment of ankle osteoarthritis. The Journal of Bone and Joint Surgery. American Volume, 103(7), 646–657.
• McAlindon, T. E., LaValley, M. P., Harvey, W. F., Price, L. L., Driban, J. B., Zhang, M., & Ward, R. J. (2017). Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: A randomized clinical trial. JAMA, 317(19), 1967–1975.
• Richette, P., Chevalier, X., Ea, H. K., Eymard, F., Henrotin, Y., Ornetti, P., Sellam, J., Cucherat, M., & Lequesne, M. (2021). Hyaluronan for knee osteoarthritis: An updated meta-analysis of trials with low risk of bias. RMD Open, 7(1), e001428.
• Sánchez, M., Anitua, E., Azofra, J., Andía, I., Padilla, S., & Mujika, I. (2012). Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clinical and Experimental Rheumatology, 30(6), 810-815.
• Sánchez, M., Delgado, D., Pompei, O., Pérez, J. C., Sánchez, P., Garate, A., Orive, G., & Padilla, S. (2021). Long-term outcome of a single platelet-rich plasma injection for early and moderate knee osteoarthritis. Arthroscopy, Sports Medicine, and Rehabilitation, 3(6), e1787–e1796.
• Wijn, S. R., Rovers, M. M., van Tienen, T. G., & Hannink, G. (2020). Intra-articular corticosteroid injections increase the risk of requiring a total knee arthroplasty. The Bone & Joint Journal, 102-B(5), 586–592.

SEO Tags: Knee Osteoarthritis, PRP Injection, Hyaluronic Acid, Ketorolac, Corticosteroid Injection, Integrative Chiropractic, Knee Pain Relief, Functional Medicine, Regenerative Medicine, Dr. Alex Jimenez, Knee Arthroplasty Prevention, Biomechanics, Chondrotoxicity, Non-Surgical Knee Treatment, Meniscal Tear, PRP Dose, High-Dose PRP, Rotator Cuff, Physician Burnout, Cash-Based Practice, Healthcare Business